• AAPL 166.82
  • TSLA 144.61
  • AMZN 179.515
  • MSFT 407.055
  • INTC 34.27
  • EURUSD 1.0704
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. PINK /
  3. TLOG.PINK

TetraLogic Pharmaceuticals Corp (TLOG PINK) stock market data APIs

$0.0001 0(0%) as of April 22, 2024

TetraLogic Pharmaceuticals Corp Financial Data Overview

0.0001
0.0001
-
0.0001
0.0001
0.0001-0.0001
459 K
24 465 K
0
0
2.439
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'TLOG',
Type: 'Common Stock',
Name: 'TetraLogic Pharmaceuticals Corp',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
ISIN: NULL,
CUSIP: NULL,
CIK: '1361248',
EmployerIdNumber: '42-1604756',
FiscalYearEnd: 'December',
IPODate: '2013-12-12',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

TetraLogic Pharmaceuticals Corp Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -21 140 180
  • Earnings Per Share -0.01
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get TetraLogic Pharmaceuticals Corp Earnings via APIs

  • Latest Release 2024-03-01
  • EPS/Forecast 0

Get TetraLogic Pharmaceuticals Corp End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get TetraLogic Pharmaceuticals Corp latest news via APIs

TetraLogic Pharmaceuticals Corporation Announces Completion of Sale of SMAC Mimetic and HDAC Inhibitor Assets to Medivir AB

PAOLI, Pa., Dec. 29, 2016 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) (“TetraLogic” or “Company”) and its wholly-owned subsidiary TetraLogic Research and Develop...
  • BIRINAPANT
  • NASDAQ:TLOG
  • SHAPE
  • TETRALOGIC PHARMACEUTICALS

TetraLogic Announces Agreements to Sell SMAC mimetic and HDAC inhibitor assets to Medivir and to Restructure its Convertible Senior Notes and Delisting of Common Stock

PAOLI, Pa., Nov. 02, 2016 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) (“TetraLogic” or “Company”), a clinical-stage biopharmaceutical company focused on discover...
  • BIRINAPANT
  • NASDAQ:TLOG
  • SHAPE
  • TETRALOGIC PHARMACEUTICALS
Do you have any questions?
support@eodhistoricaldata.com